Purpose Accurate evaluation of breast cancer on bioptic samples is of fundamental
importance to guide therapeutic decisions, especially in the neoadjuvant or metastatic …

Background With the increasing use of neoadjuvant chemotherapy and minimally invasive
ablative therapy in breast cancer, pretreatment assessment of tumour grade on core needle …

Purpose Histopathological biomarkers guide breast cancer management. Testing
histopathological biomarkers on both core needle biopsy (CNB) and surgical excision (SE) …

Breast cancer is a disease affecting an increasing number of women worldwide. Several
efforts have been made in the last years to identify imaging biomarker and to develop …

Background Several studies have assessed the concordance of estrogen receptor (ER) and
human epidermal growth factor receptor 2 (HER2) status between core needle biopsy (CNB) …

Purpose We evaluated the concordance between core needle biopsy (CNB) and surgical
specimens on examining intrinsic biological subtypes and receptor status, and determined …

Background Adjuvant therapy decisions may be partly based on the results of a multigene
quantitative reverse transcription-polymerase chain reaction (RT-PCR)-based assay: the 21 …

Background Accurate diagnostic biomarker testing is crucial to treatment decisions in breast
cancer. Biomarker testing is performed on core needle biopsies (CNB) and is often repeated …

Background Accurate molecular classification of breast core needle biopsy (CNB) tissue is
important for determining neoadjuvant systemic therapies for invasive breast cancer. The …

Background Breast spindle cell malignancies are rare. No standard treatment exists.
Methods The Surveillance, Epidemiology, and End Results database was used to identify …